Biomedical Therapies

A note before you read: this article was written in 2011 and lists what practitioners were recommending then. Several of these, chelation and secretin above all, have since been tested and found not to work. None of this is medical advice; any treatment for your child is a conversation with your child’s doctor.

It is important to remember that Autism Spectrum Disorder is a disorder and not a disease that can be cured.  However, a number of biomedical therapies for the treatment of autism are recommended by various practitioners for improving a child’s well-being and mental performance.

Some of the most recognized biomedical therapies for children with ASD are: (Levy SE, 2005)

Gluten Free/Casein Free (GFCF) Diet

Gluten-Free/Casein-Free (GFCF) Diet refers to a diet in which food containing gluten and casein is removed. Gluten is a protein that exists in wheat, oats, rye, and barley. Casein is a protein found in dairy foods. It is based on speculations that gluten and casein react adversely in children with autism. Research on this hypothesis is ongoing. It has proved beneficial for some children in improving their sleep, habitual behaviors, and bowel regulation. If the GFCF diet is followed, it should first be consulted with a dietitian.

Medications

Medications that are associated with the treatment of autism are:

• Antidepressants
• Antipsychotic
• Stimulants
• Risperidone
• SSRIs
• Oxytocin
• Antidepressants
• MAOIs
• Tricyclics
• Catapres and Tenex
• Medications for anxiety
• Anti-seizure drugs
• Neuroleptics
• Atypical
• Antifungal
• Antiviral and antibacterial drugs
• Other drugs

All medications given to a child with ASD should be under the guidance of a psychiatric medical doctor in conjunction with other professionals involved in the care and therapy of the child.

Metabolism

Treatments that improve metabolic functioning are usually performed with drugs, diet and nutritional supplements in some combination. Although research is still ongoing, symptoms of autism may be reduced strikingly with some treatments. Metabolic irregularities may cause some autism spectrum disorders like:

• Phenylketonuria
• Histidinemia
• Adenylosuccinate lyase deficiency
• Dihydropyrimidine dehydrogenase deficiency
• 5prime-nucleotidase super activity
• Phosphoribosylpyrophosphate synthetase deficiency

Secretin

Secretin treatment may be used for children with autism. It is intended to raise the amount of pancreaticobiliary fluids, which may lead to gastrointestinal changes. It was once claimed to improve social and behavioral skills after repeated injections; controlled trials since have found secretin no better than placebo. It is given intravenously.

Vitamins

Some practitioners have claimed that the cis form of vitamin A supports the parts of the brain that control speech and vision; this is not established. As children with autism have weaknesses in speech and vision, it may be useful. Vitamin B12 is also another important vitamin that is required for the healthy functioning of the brain. It helps in producing the protective layer around the nerves in the brain. It also helps in the production of neurotransmitters that are critical for communication inside the brain. The required nutrients are absorbed in the body with the help of vitamin B12, which helps in improving the nervous system and reduces the symptoms of autism.

Chelation Therapy

Chelation is commonly used in the treatment of lead poisoning. It is an unconventional and controversial form of treatment of autism. A large amount of mercury or other metal in the body may cause some autism symptoms.  Ethylene Diamine Tetraacetic acid (EDTA) is known to be a chelating agent. When it is introduced into the bloodstream intravenously or orally, it bonds with metals like mercury. It is passed out of the body in stool, along with the metal. Chelation has not been shown to help autism, and it has caused deaths in children; it is not a treatment for autism.

References:   

Levy SE, H. S. (2005). Novel treatments for Autistic Spectrum Disorders. Ment Retard Dev Disabil Res Rev., 11(2):131-42.

Copyright © by Special Learning Inc. All right reserved.

No part of this article may be reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles and reviews. For information, contact Special Learning Inc., at: contact@special-learning.com